|

Natural
Progesterone: The Feel-Good Hormone - Part II (read
part I)
by Ward Dean, M.D.
Some of the most common symptoms
physicians hear from their female patients are problems with
weight gain, fatigue, loss of libido, depression, headaches,
joint pain and mood swings. Other frequently discovered problems
include uterine fibroids, cancer, fibrocystic breast disease,
menstrual problems, autoimmune disorders, pre-menopausal bone
loss and a high incidence of osteoporosis after menopause. Many
physicians and scientists are becoming increasingly aware of a
common link between these symptoms and diseases and that common
link is often an imbalance between the primary female sex
hormones, progesterone and estrogen.(1)
Studies show that by restoring the estrogen: progesterone
hormonal balance to normal levels, many women report dramatic
improvement. Researchers in one study were so impressed with the
effectiveness of topically-applied natural progesterone, they
reported that [Our] results suggest that osteoporosis is not an
irreversible condition. But first its important to understand
what makes these complex chemical messengers tick.
The word hormone comes from a Greek word meaning arouse to
activity. Progesterone and estrogen along with DHEA,
pregnenolone, and cortisol are classified as steroid hormones.
Progesterone is made in the ovaries of menstruating women. It is
produced by the corpus luteum at the time of ovulation (20-25
mg./day), and by the placenta during pregnancy (up to 300-400
mg./day). Progesterone is a precursor to most steroid hormones
and performs a myriad of different functions. (Table I)
(2,3,4,5,6)
| TABLE I :
|
FUNCTIONS OF
PROGESTERONE |
- Builds bones and protects
against osteoporosis
- Helps burn fat for energy
- Maintains the uterine lining
- Necessary for the fetus to
survive until birth
- Acts as a natural diuretic
- Maintains thyroid hormone
action for thermogenesis (fat burning)
- Normalizes blood clotting
- Restores and maintains sex
drive
- Helps prevent breast and
endometrial cancer
|
The Estrogen Dominance Syndrome
According to research pioneer Dr. John Lee, many women suffer
from a syndrome known as Estrogen Dominance. Estrogen, unopposed
by progesterone, results in a number of adverse effects. These
include hypertension, salt and water retention, abnormal blood
clotting, excessive body fat, hypothyroidism, painful breasts,
fibrocystic breast disease, increased risk of gallbladder
disease and gallstones, liver dysfunction, increased risk of
endometrial cancer of the uterus and breast cancer.
Estrogen dominance occurs at the age of menopause when
progesterone production virtually ceases, plummeting to
approximately 1% of its premenopausal level. At the same time
the production of estrogen only falls to about 50% of its
premenopausal level. This dramatically alters the estrogen:
progesterone ratio, and the estrogen becomes toxic to the body
without progesterone to stop it. As a result, the risks for
breast and uterine cancer, fibrocystic breasts, ovarian cysts,
uterine fibroids, cervical erosions and/or dysplasia, and
osteoporosis rise.
The problems of estrogen dominance are not confined to
menopausal woman only. Today, it is extremely common for women
to experience recurring menopause-type complaints that begin 10
to 15 years before the time of their menopause when menstruation
ceases. Woman as young as thirty years of age are complaining of
menopause-type problems. This is known as pre-menopause
syndrome. The typical complaints are: fatigue, depression, water
retention, weight gain, mood swings, loss of sex drive,
irritability, headaches, slow metabolism and cravings for
sweets.(7)
Progesterone and Osteoporosis
One common and almost universal change with age is loss of bone
density. When this loss becomes severe enough, it is diagnosed
as osteoporosis, the disfiguring and potentially fatal
brittle-bone disease. In many western countries, patients with
hip fractures occupy more hospital beds than patients with any
other disease. For more than fifty years physicians have
believed that lack of estrogen was the primary cause of
osteoporosis. Quite simply, a lack of estrogen does not cause
osteoporosis.(8) For example, tamoxifen citrate, an
anti-estrogen drug that is prescribed for breast cancer-prone
women, blocks the uptake of estrogen hormones. If lack of
estrogen were the cause of osteoporosis, then tamoxifen would
increase bone resorption and cause loss of bone density.
Tamoxifen does not cause that to occur. (9) In addition, there
is significant bone loss during the 10 to 15 years before
menopause, despite an ample supply of estrogen. But during that
time, there is often a shortage of progesterone. Although
estrogen inhibits the bone-destroying osteoclast cells, it
cannot rebuild bone.(10,11)
On the other hand, progesterone rebuilds bone by stimulating the
osteoblast cells that remineralize and restore bone mass.
Supplementing with natural progesterone has proved useful to
prevent and heal osteoporosis.(11) Osteoporosis becomes most
severe following menopause when womens bodies stop producing
progesterone. Dr. John Lee and many other physicians say
progesterone is a key to maintaining healthy bones.(12,13)
Dr. Lee reported in the July, 1990 issue of International
Clinical Nutrition Review on the effectiveness of natural
progesterone. It was common to see a 10 percent increase (in
bone density) in the first six to 12 months, and an annual
increase of three to five percent until stabilizing at the
levels of healthy 35-year-olds. Lee adds, The occurrences of
osteoporotic fractures dropped to zero. Dr. Lees results run
counter to current medical thinking about osteoporosis. The
results of this study suggest that osteoporosis is not an
irreversible condition, he says. Reversal has been demonstrated
by the bone density tests and by the clinical results. This
cannot be said of any other conventional therapy for
osteoporosis. (14,15,16,17)
The Progesterone Solution
As mentioned previously, estrogen dominance causes many problems
for women, including PMS, premenopausal syndrome, and
osteoporosis. Since these conditions have the common cause of
estrogen dominance and relative progesterone deficiency, they
also have a remarkably simple common cure i.e., supplement the
body with physiologic dosages of natural progesterone
(approximately 20-30 mg./day) to overcome the estrogen dominance
and reestablish hormonal balance. (7)
Natural vs. Synthetic Progesterone
Theres a world of difference between natural progesterone and
synthetic progesterone, the type most frequently prescribed by
orthodox physicians. Provera, the most frequently prescribed
synthetic progesterone is not really progesterone at all it is a
progestin. Progestins are synthetic progesterone-like compounds
that are manufactured by pharmaceutical companies. These
synthetic progesterones are far more powerful than the bodys own
natural progesterone and are metabolized as foreign substances
into toxic by-products. These synthetic progesterones can
gravely interfere with the bodys own natural progesterone, thus
creating other hormone-related health problems and further
exacerbating estrogen dominance. (18) Side effects of synthetic
progesterone include increased risk of cancer, abnormal
menstrual flow, nausea, depression, masculinizing effects, and
fluid retention.(19, 20)
Natural progesterone is nearly identical to what the body
produces. It is manufactured in scientific laboratories from
wild yams and soy beans. On the other hand, yam-derived natural
progesterone should not be confused with yam extracts that are
sold in health food stores. The body easily converts natural
progesterone into the identical molecule made by the body. The
body cannot, however, convert the yam extracts into
progesterone.21 Adverse side effects are very rare with natural
progesterone.(22) The only side effect of concern is that it
might slightly alter the timing of the menstrual cycle, when
taken inappropriately.
Routes of Progesterone Delivery
Natural progesterone can be administered orally, topically, or
by injection. However, I believe that the best way is topically
(transdermally). Transdermal delivery is gaining in popularity
as evidenced by the growing use of estrogen, testosterone,
nitroglycerine (for angina) and even nicotine patches.(23,24)
Equivalent dosages of transdermal natural progesterone are 5 to
7 times more effective than orally ingested natural
progesterone. Only 10-15% of the orally ingested progesterone
reaches the bloodstream. (25,23) Therefore, it is necessary to
take much higher doses, 100-200 mg./day, of oral progesterone to
obtain the equivalent benefit of 20-30 mg./day of transdermal
progesterone.
Once progesterone reaches a saturation level in the underlying
skin tissue, it diffuses into the capillaries, then passes into
the general blood circulation for use by the body. Some women
feel effects in less than a week of usage. For those who are
especially deficient in progesterone, it may take two to three
months to restore optimum levels. (7,26)
Not All Topical Progesterones Are the Same
A word of warning: not all trans-dermal delivery preparations of
progesterone are capable of carrying the hormone through the
skin. Adding progesterone to a typical cosmetic moisturizer
(which is what many companies do) often results in a product
that does not effectively penetrate the skin.
An ideal delivery vehicle is an oil-water emulsion that contains
components of the fatty tissue of the skin, as well as
permeation enhancers and stabilizers in a synergistic balance.
The permeation enhancers enable the progesterone to pass the
skin barrier. (27) A transdermal progesterone cream should
contain at least 400 mg. of natural progesterone per ounce. Each
one-half teaspoon application would thereby supply a minimum of
26 mg. of progesterone. Independent studies reveal that many
commercial progesterone cream products contain less than 15 mg.
of progesterone per ounce. In fact, some of these creams
containing as little as 2 mg. of progesterone per ounce! (28) It
should be emphasized that creams containing only wild yam
extract (diosgenin) but no U.S.P. progesterone have absolutely
no effect on the level of progesterone in the body.
Highly recommended
source for nutrients.

How did we
qualify VRP?
References:
1. Lipsett, M.P. Steroid hormones, in Reproductive
Endocrinology, Physiology, and Clinical Management. Yen, S.S.C.,
and R.B. Jaffe, eds. Philadelphia: W.B. Saunders Co., 1978.
2. Goodman, L. & Gilman, A. The Pharmacological Basis of
Therapeutics. Toronto, McMillan, 8th edition, chapter 58, 1990.
3. Thomas, J. & Gillham, B. Wills Biochemistry Basis of
Medicine. Oxoford, Butterworth-Heinenman Ltd. 1989.
4. Ellison, P,T., et al, The ecological context of human ovarian
function. Human Reproduction. 8:2248-58, 1993.
5. Elks, Peripheral effects of steroid hormones, implications
for patient management, JAMWA. 48:41- 55, 1993.
6. Tietz, N., ed. Textbook of Clinical Chemistry, Philadelphia,
W.B. Sanders Co., 1085-1171, 1986.
7. Lee, J.R. What Your Doctor May Not Tell You About Menopause.
Warner Books, May, 1996.
8. Barzel, U.S. Estrogens in the prevention and treatment of
postmenopausal osteoporosis. Am J of Med. 85:847-50, 1988.
9. Love, R., et al. Effects of tamoxifen on women with breast
cancer, New England Journal of Medicine, 326: 852-6, 1992.
10. Harrisons Principles of Internal Medicine. 12th edition ,
1991.
11. Prior, J.C. Progesterone as a bone-trophic hormone. Endocr
Rev,11:386-98, 1990.
12. Prior, J.C. et al, Progesterone and the prevention of
osteoporosis, Canadian Journal of Obstetrics/Gynecology & Womens
Health Care, 3:178-84, 1991.
13. Lee, J.R. Is natural progesterone the missing link in
osteoporosis prevention and treatment? Medical Hypotheses,
35:316-18, 1991.
14. Lee, J.R. Osteoporosis reversal: the role of progesterone
Intern Clin Nutr Rev, 10:384-91, 1990.
15. Lee, J.R. Osteoporosis reversal with transdermal
progesterone (letter). Lancet, 336:1327, 1990.
16. Lee, J.R. Slowing the Aging Process with Natural
Progesterone, BLL Publ. California, USA, 1994.
17. Lees, B., et al. Differences in proximal femur density over
two centuries. Lancet, 341:673-75, 1993.
18. Edgren, R.A. Clinical Use of sex hormones, Year Book Medical
Publications, 1980.
19. Physicians Desk Reference (PDR). 46th Edition, Montvale,
N.J. Medical Economics Data, 2356, 1992.
20. Bergkvist, L., et al . The risk of breast cancer after
estrogen and estrogen-progestin replacement. New England Journal
of Medicine, 321:293-97, 1989.
21. Hargrove, et al. Menopausal hormone replacement therapy with
continuous daily oral micronized estradiol and progesterone.
Sciences, Vol. 84, No. 9, Sept. 1995. Pages 1144-1146, 1995.
22. Ottoson, U.B., et al. Subtractions of high-density
lipoprotein cholesterol during estrogen replacement therapy: a
comparison between progestins and natural progesterone. American
Journal of Obstetrics and Gynecology, 151:746-50,1985.
23. Johnson, et al. Permeation of steroids through human skin.
Journal of Pharmaceutical Sciences, Vol. 84, No. 9, Sept. 1995.
Pages 1144-1146, 1995.
24. Hadgraft, J. & Guy, R.H. Transdermal Drug Delivery, Volume
35, Drugs and the Pharmaceutical Sciences, Marcel Dekker, 1989.
25. Chien, Y.W. Novel Drug Delivery Systems. 2nd Ed., Drugs and
the Pharmaceutical Sciences, Volume 50, Marcel Dekker, 1992.
26. Barry, B.W. Dermatological Formulations. Percutaneous
Absorption. Drugs and the Pharmaceutical Sciences, Volume 18,
Marcel Dekker, 1983.
27. Waiters, K.A. Penetration enhancers and their use in
Transdermal Therapeutic Systems, in Transdermal Drug Delivery,
Volume 35, Drugs and the Pharmaceutical Sciences Marcel Dekker,
1989.
28. Lee, John R. What Your Doctor May Not Tell You About
Menopause Range of Progesterone Content of Body Creams & Oils
prepared by Aeron Lifecyles. Warner Books, May, 1996
Highly recommended
source of nutrients and supplements.
|